key: cord-1018767-5d3cmn2e
authors: Harvey, Nicholas C.; Cooper, Cyrus; Raisi-Estabragh, Zahra
title: Vitamin D supplementation and COVID-19 disease: safety but unproven efficacy—reply to Dr Helga Rhein
date: 2021-08-18
journal: Aging Clin Exp Res
DOI: 10.1007/s40520-021-01947-3
sha: 68f9c4a9ae9bb440375fd80bb4ebd64dd2282302
doc_id: 1018767
cord_uid: 5d3cmn2e

nan

To the editor:

We read with interest the letter from Dr Helga Rhein, responding to our rapid evidence review around vitamin D and COVID-19 disease [1] . Dr Rhein suggests that the "evidence for the benefits of avoiding vitamin D deficiency during the pandemic far outweighs the theoretical risk of overdose" [2] . Thus, "on the balance of probabilities", should we routinely supplement the population with higher dose vitamin D than the 400 IU/day suggested in the UK as the (dietary) RNI [3] ? We completely agree with Dr Rhein that 400 IU/day will not effectively ameliorate overt vitamin D deficiency. If an individual presents with symptoms and signs consistent with the metabolic consequences of vitamin D deficiency, then clearly they should be treated appropriately with more rapid replenishment [4, 5] . This is a fundamentally different scenario to that of population health. The UK Scientific Advisory Committee on Nutrition (SACN) recommendation is aimed at ensuring that 97.5% of the population have 25(OH)D > 25 nmol/l [3] . Whilst one can argue that the therapeutic window for vitamin D supplementation is wide and risks of overdose low, we are not convinced (see our response to the letter of Dr William Grant [6, 7] that this is sufficient reason to introduce population-level higher dose supplementation for prevention of COVID-19 disease when the observational evidence provides very limited support and the best conducted intervention study to date suggests no benefit [8] ). Whether such an approach might be warranted for other outcomes, or to prevent metabolic bone disease in high risk demographics, are separate questions.

Vitamin D and coronavirus disease 2019 (COVID-19): rapid evidence review

Vitamin D-let common sense prevail-on the balance of probabilities

SACN (2016) Vitamin D and health. Scientific Advisory Committe on Nutrition

Vitamin D: some perspective please

National Osteoporosis Society vitamin D guideline summary

Vitamin D and COVID-19 disease: don't believe everything you read in the papers! Reply to Dr William B. Grant

Vitamin D and coronavirus disease 2019 (COVID-19): rapid evidence review

Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial